Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

The Result of Conversion Surgery in Gastric Cancer Patients with Peritoneal Seeding

  • Kim, Se Won (Department of Surgery, Yeungnam University College of Medicine)
  • Received : 2014.10.29
  • Accepted : 2014.12.08
  • Published : 2014.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Palliative gastrectomy and chemotherapy are important options for peritoneal seeding of gastric cancer. The treatment stage IV gastric cancer patient who respond to induction chemotherapy, is converted to gastrectomy (conversion therapy or conversion surgery). This study explored the clinical outcomes of gastric cancer patients with peritoneal seeding who had undergone conversion therapy. Materials and Methods: Between 2003 and 2012, gastric cancer patients with peritoneal seeding, as determined by preoperative or intraoperative diagnosis were reviewed retrospectively. Clinicopathologic characteristics and clinical outcomes of patients with peritoneal seeding were analyzed. Results: Forty-three patients were enrolled. Eighteen patients had undergone conversion surgery and 25 patients continued conventional chemotherapy. Among the 18 conversion patients, 10 received clinically curative resection. The median follow-up period was 28.5 months (range 8 to 60 months) and the total 3-year survival rate was 16.3%. The median survival time of the patients who received clinically curative conversion therapy was 37 months, and the 3-year survival rate was 50%. The median follow-up for non-curative gastrectomy patients was 18 months. No patient treated using chemotherapy survived to 3 years; the median survival time was 8 months. The differences in survival time between the groups was statistically significant (P<0.001). Conclusions: In terms of survival benefits for gastric cancer patients with peritoneal seeding, clinically curative conversion therapy resulted in better clinical outcomes.

Keywords

References

  1. Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982;8:1-11. https://doi.org/10.1016/0360-3016(82)90185-7
  2. Landry J, Tepper JE, Wood WC, Moulton EO, Koerner F, Sullinger J. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990;19:1357-1362. https://doi.org/10.1016/0360-3016(90)90344-J
  3. Wisbeck WM, Becher EM, Russell AH. Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 1986;7:13-18 https://doi.org/10.1016/S0167-8140(86)80120-7
  4. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530-535. https://doi.org/10.1007/BF01675656
  5. Ryu KW, Mok YJ, Kim SJ, Kim CS. Prognostic factors in advanced gastric cancer with peritoneal carcinomatosis. J Korean Surg Soc 2000;59:786-792.
  6. Funaki H, Fujita J, Morioka E, Kaida D, Ohnishi T, Ohno Y, et al. Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer. Gan To Kagaku Ryoho 2013;40: 1615-1617.
  7. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma: 2nd English edition. Gastric Cancer 1998;1:10-24. https://doi.org/10.1007/PL00011681
  8. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14:113-123. https://doi.org/10.1007/s10120-011-0042-4
  9. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 2000;58:96-107. https://doi.org/10.1159/000012086
  10. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 1994;14:2131-2134.
  11. Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am 2003;12:703-727. https://doi.org/10.1016/S1055-3207(03)00048-6
  12. Kuramoto M, Shimada S, Ikeshima S, Matsuo A, Yagi Y, Matsuda M, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 2009;250:242-246. https://doi.org/10.1097/SLA.0b013e3181b0c80e
  13. Stern JL, Denman S, Elias EG, Didolkar M, Holyoke ED. Evaluation of palliative resection in advanced carcinoma of the stomach. Surgery 1975;77:291-298.
  14. Kim HI, Ha TK, Kwon SJ. Prognostic factors in gastric cancer patients with peritoneal carcinomatosis. J Gastric Cancer 2010; 10:126-132. https://doi.org/10.5230/jgc.2010.10.3.126
  15. Hünerbein M, Rau B, Hohenberger P, Schlag PM. The role of staging laparoscopy for multimodal therapy of gastrointestinal cancer. Surg Endosc 1998;12:921-925. https://doi.org/10.1007/s004649900747
  16. Song SC, Lee SL, Cho YK, Han SU. The role and efficacy of diagnostic laparoscopy to detect the peritoneal recurrence of gastric cancer. J Korean Gastric Cancer Assoc 2009;9:51-56. https://doi.org/10.5230/jkgca.2009.9.2.51
  17. Yonemura Y, Bandou E, Sawa T, Yoshimitsu Y, Endou Y, Sasaki T, et al. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 2006;32:661-665. https://doi.org/10.1016/j.ejso.2006.03.007
  18. Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al; Association Francaise de Chirurgie. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2010;17:2370-2377. https://doi.org/10.1245/s10434-010-1039-7
  19. Badgwell B, Cormier JN, Krishnan S, Yao J, Staerkel GA, Lupo PJ, et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol 2008;15:2684-2691. https://doi.org/10.1245/s10434-008-0055-3
  20. Seo YJ, Bae JM, Kim SW, Kim SW, Song SK. Different clinical outcomes of stage iv gastric cancer according to the curability of surgery. J Korean Surg Soc 2009;77:170-176. https://doi.org/10.4174/jkss.2009.77.3.170
  21. Hioki M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kinoshita T. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg 2010;34:555-562. https://doi.org/10.1007/s00268-010-0396-5
  22. Pollock RE, Roth JA. Cancer-induced immunosuppression: implications for therapy? Semin Surg Oncol 1989;5:414-419. https://doi.org/10.1002/ssu.2980050607
  23. Yoon SY, Kim MG, Oh ST. The impact of preoperative chemotherapy on the surgical management of unresectable gastric cancer. J Korean Gastric Cancer Assoc 2009;9:269-274. https://doi.org/10.5230/jkgca.2009.9.4.269

Cited by

  1. The Value of Palliative Gastrectomy for Gastric Cancer Patients With Intraoperatively Proven Peritoneal Seeding vol.94, pp.27, 2014, https://doi.org/10.1097/md.0000000000001051
  2. Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score‐matched analysis vol.5, pp.10, 2016, https://doi.org/10.1002/cam4.877
  3. Usefulness of diagnostic laparoscopy with 5-aminolevulinic acid (ALA)-mediated photodynamic diagnosis for the detection of peritoneal micrometastasis in advanced gastric cancer after chemotherapy vol.46, pp.12, 2016, https://doi.org/10.1007/s00595-016-1328-2
  4. Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru? vol.19, pp.3, 2014, https://doi.org/10.1007/s10120-016-0609-1
  5. Clinical Significance of Staging Laparoscopy in the Diagnosis of Peritoneal Dissemination of Advanced Gastric Cancer vol.77, pp.11, 2014, https://doi.org/10.3919/jjsa.77.2631
  6. Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report vol.5, pp.6, 2016, https://doi.org/10.3892/mco.2016.1065
  7. Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis vol.8, pp.12, 2017, https://doi.org/10.7150/jca.18932
  8. Radical Gastrectomy After Chemotherapy May Prolong Survival in Stage IV Gastric Cancer: A Korean Multi-institutional Analysis vol.42, pp.10, 2014, https://doi.org/10.1007/s00268-018-4635-5
  9. Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-bound paclitaxel and gemcitabine chemotherapy: case report and literature review vol.7, pp.1, 2014, https://doi.org/10.1007/s13691-017-0311-0
  10. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer vol.18, pp.3, 2014, https://doi.org/10.5230/jgc.2018.18.e32
  11. Conversion surgery for gastric cancer patients: A review vol.10, pp.11, 2014, https://doi.org/10.4251/wjgo.v10.i11.398
  12. Pathological complete response from oral chemotherapy combined with trans-arterial chemotherapy and embolization in an unresectable gastric cancer patient : A case report vol.98, pp.25, 2014, https://doi.org/10.1097/md.0000000000016075
  13. Risk-stratification model to select conversion surgery for advanced gastric cancer patients vol.31, pp.1, 2014, https://doi.org/10.21147/j.issn.1000-9604.2019.01.13
  14. Issues on peritoneal metastasis of gastric cancer: an update vol.17, pp.1, 2014, https://doi.org/10.1186/s12957-019-1761-y
  15. Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker vol.12, pp.1, 2020, https://doi.org/10.3390/cancers12010086
  16. Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers vol.20, pp.3, 2014, https://doi.org/10.5230/jgc.2020.20.e20
  17. Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis vol.52, pp.1, 2014, https://doi.org/10.1007/s12029-020-00519-4
  18. Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis vol.147, pp.8, 2014, https://doi.org/10.1007/s00432-021-03516-7